Filters: Keyword is Tumor Cells, Cultured [Clear All Filters]
2006
Tartis MS, McCallan J, Lum AFH, LaBell R, Stieger SM, Matsunaga TO, Ferrara KW.
2006. Therapeutic effects of paclitaxel-containing ultrasound contrast agents.. Ultrasound in medicine & biology. 32(11):1771-80. Abstract
Dolan BP, Gibbs KD, Ostrand-Rosenberg S.
2006. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.. Journal of immunology (Baltimore, Md. : 1950). 176(3):1447-55. Abstract
Thamm DH, Dickerson EB, Akhtar N, Lewis R, Auerbach R, Helfand SC, MacEwen GE.
2006. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line.. Research in veterinary science. 81(1):76-86. Abstract
2004
Akhtar N, Padilla ML, Dickerson EB, Steinberg H, Breen M, Auerbach R, Helfand SC.
2004. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.. Neoplasia (New York, N.Y.). 6(2):106-16. Abstract
2003
Bianco SR, Sun J, Fosmire SP, Hance K, Padilla ML, Ritt MG, Getzy DM, Duke RC, Withrow SJ, Lana S et al..
2003. Enhancing antimelanoma immune responses through apoptosis.. Cancer gene therapy. 10(9):726-36. Abstract
2000
1999
Phillips BS, Padilla ML, Dickerson EB, Lindstrom MJ, Helfand SC.
1999. Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs.. Veterinary immunology and immunopathology. 70(3-4):189-201. Abstract
Soergel SA, MacEwen EG, Vail DM, Potter DM, Sondel PM, Helfand SC.
1999. The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanoma.. Journal of immunotherapy (Hagerstown, Md. : 1997). 22(5):443-53. Abstract
Helfand SC, Dickerson EB, Munson KL, Padilla ML.
1999. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.. Cancer research. 59(13):3119-27. Abstract







